Patents by Inventor Ervin Nagy

Ervin Nagy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11859191
    Abstract: This disclosure is related to plant-optimized recombinant nucleic acids encoding Cpf1 and their use in planta. Also disclosed are compositions, expression cassettes, and plant cells comprising the recombinant nucleic acids as well as methods and kits for modifying a target sequence in a plant genome using the recombinant nucleic acids.
    Type: Grant
    Filed: August 3, 2022
    Date of Patent: January 2, 2024
    Assignee: Monsanto Technology LLC
    Inventors: Stanislaw Flasinski, Elysia Krieger, Ervin Nagy, Krishnakumar Sridharan, Xudong Ye
  • Publication number: 20230340441
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for cleaving a target DNA in eukaryotic cells with a guide RNA capable of hybridizing with a target sequence and an RNA-guided DNA nuclease are provided. Also provided are vectors and vector systems which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR systems.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 26, 2023
    Applicant: Monsanto Technology LLC
    Inventors: Jaishree M. CHITTOOR, Ervin NAGY, Keith H. TURNER
  • Patent number: 11692182
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for cleaving a target DNA in eukaryotic cells with a guide RNA capable of hybridizing with a target sequence and an RNA-guided DNA nuclease are provided. Also provided are vectors and vector systems which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR systems.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: July 4, 2023
    Assignee: Monsanto Technology LLC
    Inventors: Jaishree Chittoor, Ervin Nagy, Keith H. Turner
  • Publication number: 20230193302
    Abstract: This disclosure is related to plant-optimized recombinant nucleic acids encoding Cpfl and their use in planta. Also disclosed are compositions, expression cassettes, and plant cells comprising the recombinant nucleic acids as well as methods and kits for modifying a target sequence in a plant genome using the recombinant nucleic acids.
    Type: Application
    Filed: August 3, 2022
    Publication date: June 22, 2023
    Applicant: Monsanto Technology LLC
    Inventors: Stanislaw FLASINSKI, Elysia KRIEGER, Ervin NAGY, Krishnakumar SRIDHARAN, Xudong YE
  • Publication number: 20220403401
    Abstract: The invention provides compositions and methods useful for modulating protein expression in eukaryotic cells. The invention also provides transgenic plants, edited plant cells, plant parts, and seeds comprising depleted or optimized Kozak sequences and methods of their use.
    Type: Application
    Filed: June 9, 2022
    Publication date: December 22, 2022
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Keith DECKER, Bryan GONTAREK, Natalia IVLEVA, Hong LI, Matthew MARENGO, Ervin NAGY, Brent O'Brien, Qungang QI, Graziana TARAMINO
  • Publication number: 20220348942
    Abstract: The present disclosure relates to compositions and methods related to using the CAST system to provide targeted transposition of desired sequences into plant genomes. Several embodiments relate to a method for producing a megalocus on a plant chromosome comprising: (a) obtaining a plant comprising a first locus, wherein the first locus comprises an endogenous trait locus or a transgene; (b) providing to the plant tnsB, tnsC, tniQ, Cast 2k, a guide nucleic acid and a donor cassette; and (c) selecting a progeny plant produced from step (b) wherein targeted transposition of the donor cassette has occurred at a second locus targeted by the guide nucleic acid, wherein the first and second locus are genetically linked but physically separate.
    Type: Application
    Filed: August 5, 2020
    Publication date: November 3, 2022
    Applicant: Monsanto Technology LLC
    Inventors: Larry GILBERTSON, Ervin NAGY, Thomas REAM, Linda RYMARQUIS, Xudong YE
  • Patent number: 11414669
    Abstract: This disclosure is related to plant-optimized recombinant nucleic acids encoding Cpf1 and their use in planta. Also disclosed are compositions, expression cassettes, and plant cells comprising the recombinant nucleic acids as well as methods and kits for modifying a target sequence in a plant genome using the recombinant nucleic acids.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: August 16, 2022
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Stanislaw Flasinski, Elysia Krieger, Ervin Nagy, Krishnakumar Sridharan, Xudong Ye
  • Publication number: 20220162625
    Abstract: The present disclosure relates to compositions and methods for improving site-directed integration frequency in the genome of plant cells.
    Type: Application
    Filed: November 10, 2021
    Publication date: May 26, 2022
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: John BRADLEY, Larry A. GILBERTSON, Ervin NAGY, Christine SHYU, Peizhen YANG, Xudong YE
  • Publication number: 20210380956
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for editing genomic DNA in eukaryotic cells with a CRISPR-associated transposase are provided. Also provided are vectors and vector systems which encode one or more CRISPR-associated transposases, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR-associated transposases.
    Type: Application
    Filed: April 9, 2021
    Publication date: December 9, 2021
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Jaishree M. CHITTOOR, Ervin NAGY
  • Publication number: 20210147862
    Abstract: This invention relates to recombinant nucleic constructs comprising a DNA binding domain, an endonuclease and a reverse transcriptase and methods of use thereof for modifying nucleic acids in plants.
    Type: Application
    Filed: October 23, 2020
    Publication date: May 20, 2021
    Inventors: Aaron Hummel, Joseph Matthew Watts, Shai Joshua Lawit, Nathaniel Graham, Larry Gilbertson, Ervin Nagy, Linda Rymarquis
  • Patent number: 10995327
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for editing genomic DNA in eukaryotic cells with a CRISPR-associated transposase are provided. Also provided are vectors and vector systems which encode one or more CRISPR-associated transposases, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR-associated transposases.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: May 4, 2021
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Jaishree M. Chittoor, Ervin Nagy
  • Publication number: 20200080096
    Abstract: This disclosure is related to plant-optimized recombinant nucleic acids encoding Cpf1 and their use in planta. Also disclosed are compositions, expression cassettes, and plant cells comprising the recombinant nucleic acids as well as methods and kits for modifying a target sequence in a plant genome using the recombinant nucleic acids.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 12, 2020
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Stanislaw FLASINSKI, Elysia KRIEGER, Ervin NAGY, Krishna SRIDHARAN, Xudong YE
  • Publication number: 20190093090
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for editing genomic DNA in eukaryotic cells with a CRISPR-associated transposase are provided. Also provided are vectors and vector systems which encode one or more CRISPR-associated transposases, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR-associated transposases.
    Type: Application
    Filed: December 29, 2016
    Publication date: March 28, 2019
    Inventors: Jaishree M. CHITTOOR, Ervin NAGY
  • Publication number: 20180362943
    Abstract: Provided herein are systems, methods, and compositions for the modification of target DNA sequences. More particularly, systems, methods, and compositions for cleaving a target DNA in eukaryotic cells with a guide RNA capable of hybridizing with a target sequence and an RNA-guided DNA nuclease are provided. Also provided are vectors and vector systems which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods for identifying and validating novel CRISPR systems.
    Type: Application
    Filed: October 7, 2016
    Publication date: December 20, 2018
    Applicant: Monsanto Technology LLC
    Inventors: Jaishree M. Chittoor, Ervin Nagy, Keith H. Turner